Logo 1 Logo 2

Clinical Trial Details

Trial ID: L4394
Source ID: NCT01159249
Associated Drug: Vildagliptin
Title: Long-term Safety Study of Vildagliptin in Patients With Type 2 Diabetes
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Type 2 Diabetes
Interventions: DRUG: Vildagliptin
Outcome Measures: Primary: Measure AEs, vital signs, laboratory evaluations, 52 weeks | Secondary: HBA1c, 52 weeks|Fasting Plasma Glucose, 52 weeks|Fasting Insulin, 52 weeks|Fasting C-peptide, 52 weeks|HOMA-B, 52 weeks
Sponsor/Collaborators: Sponsor: Novartis Pharmaceuticals
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE3
Enrollment: 245
Study Type: INTERVENTIONAL
Study Designs: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2010-06
Completion Date: 2012-01
Results First Posted:
Last Update Posted: 2020-12-17
Locations: Novartis Investigative Site, Hunabashi, Chiba, 274-0805, Japan|Novartis Investigative Site, Chikushino, Fukuoka, 818-0036, Japan|Novartis Investigative Site, Itoshima-shi, Fukuoka, 819-1102, Japan|Novartis Investigative Site, Koriyama, Fukushima, 963-8851, Japan|Novartis Investigative Site, Kobe, Hyogo, 658-0064, Japan|Novartis Investigative Site, Kawasaki, Kanagawa, 210-0852, Japan|Novartis Investigative Site, Kawasaki, Kanagawa, 212-0024, Japan|Novartis Investigative Site, Yokohama-city, Kanagawa, 221-0077, Japan|Novartis Investigative Site, Yokohama, Kanagawa, 221-0065, Japan|Novartis Investigative Site, Izumisano, Osaka, 598-0048, Japan|Novartis Investigative Site, Hannou, Saitama, 357-0024, Japan|Novartis Investigative Site, Hiki-Gun, Saitama, 355-0328, Japan|Novartis Investigative Site, Kawaguchi, Saitama, 332-0012, Japan|Novartis Investigative Site, Koshigaya city, Saitama, 343-0826, Japan|Novartis Investigative Site, Tokorozawa, Saitama, 359-1161, Japan|Novartis Investigative Site, Edogawa-ku, Tokyo, 134-0084, Japan|Novartis Investigative Site, Hachioji, Tokyo, 192-0046, Japan|Novartis Investigative Site, Katsushika-ku, Tokyo, 125-0041, Japan|Novartis Investigative Site, Minato-ku, Tokyo, 108-0075, Japan|Novartis Investigative Site, Shinagawa-ku, Tokyo, 141-0032, Japan|Novartis Investigative Site, Toshima-ku, Tokyo, 171-0021, Japan|Novartis Investigative Site, Fukuoka, 807-0857, Japan|Novartis Investigative Site, Fukuoka, 816-0094, Japan|Novartis Investigative Site, Fukuoka, 819-0168, Japan
URL: https://clinicaltrials.gov/show/NCT01159249

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress
D432 Vildagliptin small molecule DB04876 Details